Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
BeiGene
BeiGene
Medical College of Wisconsin
Jonsson Comprehensive Cancer Center
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)